Skip to search.
 TSX Down 0.34% TSX Ventures Down 0.60%

More On DNDN

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Dendreon Corp. (DNDN)

-NasdaqGS
0.13 0.00(0.00%) Nov 18, 4:00PM EST
Add to Portfolio
Prev Close:0.13
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:0.81
Beta:2.89
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.11 - 3.52
Volume:0
Avg Vol (3m):4,903,030
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DNDN 0.00%N/A
NWBOUp 5.22%451.70M
PGNXUp 3.69%488.97M
SNYUp 0.54%127.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback